$116.14
0.0% Today
as of Jul 22, 16:26 ET
Last 30 days
Recent Press Releases & News
mixed
▲ 1
● 22
▼ 2
Xylem (XYL) Reports Next Week: Wall Street Expects Earnings Growth
JPMorgan Downgrades Xylem to Neutral From Overweight, Cuts Price Target to $130 From $140
Jefferies Adjusts Price Target on Xylem to $145 From $140, Maintains Buy Rating
Overview
52-week range
$105
$154
22% of range
Avg surprise (last 2)
+9.5%
Avg reaction (last 1)
+2.3%
100% positive
Latest IV / EM
49%
EM ±11.1% · $115 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Mar 31, 2026 | Mar 2026 | $0.79 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $0.93 | — | — | — | — | financials |
| Thu Jul 31, 2025 | Jun/2025 | $1.26 | $1.14 | +10.5% | — | — | earnings |
| Tue Apr 29, 2025 | Mar/2025 | $1.03 | $0.95 | +8.4% | — | +2.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.89 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.80 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.63 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.63 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.45 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Jul 28, 2026 | Jun/2026 | BMO | $1.34 | $1.26 | +6.3% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.12B | — | $2.27B | $2.30B | $2.07B | — | $2.10B | $2.17B |
| Cost of revenue | $1.32B | — | $1.39B | $1.41B | $1.30B | — | $1.32B | $1.35B |
| Gross profit | $803M | — | $883M | $892M | $768M | — | $784M | $819M |
| Operating income | $244M | — | $334M | $305M | $231M | — | $280M | $253M |
| Net income | $193M | — | $227M | $226M | $169M | — | $217M | $194M |
| EPS (diluted) | $0.79 | — | $0.93 | $0.93 | $0.69 | — | $0.89 | $0.80 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $808M | $1.48B | $1.19B | $1.17B | $1.06B | $1.12B | $989M | $815M |
| Inventory | $991M | $983M | $1.03B | $1.07B | $1.02B | $996M | $1.09B | $1.06B |
| Total current assets | $4.03B | $4.64B | $4.44B | $4.37B | $4.08B | $4.10B | $4.01B | $3.78B |
| Total assets | $16.95B | $17.63B | $17.30B | $17.19B | $16.56B | $16.49B | $16.05B | $15.77B |
| Long-term debt | $1.41B | $1.41B | $1.91B | $1.93B | $1.97B | $1.98B | $1.98B | $1.98B |
| Total liabilities | $5.72B | $5.88B | $5.85B | $5.88B | $5.50B | $5.61B | $5.45B | $5.42B |
| Total equity | $10.97B | $11.48B | $11.21B | $11.07B | $10.82B | $10.64B | $10.59B | $10.34B |